Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Viral video shows COVID going to be "cash cow" for Pfizer, pharma giant issues response

Farhat Nasim30 Jan 2023 7:21 PM IST

Delhi: Brewing controversy, a video featuring an allegedly Pfizer executive claiming about how his company was exploring purposely mutating COVID...

Novartis Loses India Patent on Heart Failure Drug Vymada

Interim relief to Novartis: Delhi HC reinstates Entresto (Sacubitril-Valsartan) patent in India

Farhat Nasim27 Jan 2023 6:26 PM IST

Delhi: In an interim relief to Swiss pharma major Novartis, the Delhi High Court has reinstated Entresto (sacubitril/valsartan) patent in India amid...

ITAT allows Rs 3 crore deduction to Merck, says free samples to doctors recognized under UCPMP not violative of MCI Rules

Farhat Nasim24 Jan 2023 7:33 PM IST

Mumbai: Allowing a deduction of Rs 3 crore to pharma company Merck Limited, the Mumbai Bench of Income Tax Appellate Tribunal (ITAT) has held that the...

Sun Pharma Told to Revise Delafloxacin Phase III Trial Protocol

Delhi HC grants mark 'Sun, Sun Pharma, Sun Pharmaceuticals' status of 'well-known trademark'

Farhat Nasim22 Jan 2023 2:30 PM IST

New Delhi: The Delhi High Court has recently granted Sun Pharmaceuticals' mark 'SUN/ SUN PHARMA' the status of a 'well-known trademark' and passed a...

NPPA fixes ceiling price of 17 scheduled drugs, Details

Farhat Nasim20 Jan 2023 6:00 PM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 17 scheduled...

Health Ministry shocker in RTI reply: CDSCO, ICMR admit to multiple side effects of Covid-19 jabs

Farhat Nasim17 Jan 2023 2:04 PM IST

New Delhi: In a shocking response to an RTI query, the Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research...

Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue Sarcoma

HC grants interim injunction against use of impugned mark Dosela deceptively similar to Sun Pharma Duzela

Farhat Nasim15 Jan 2023 12:00 PM IST

New Delhi: The Delhi High Court has granted an interim injunction restraining Avighna Medicare Private Limited from selling, offering to sell,...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis in tight spot as HC stays grant of patent for Entresto amid generics fight

Farhat Nasim13 Jan 2023 11:59 AM IST

New Delhi: Amid the earlier patent of blockbuster heart failure drug Entresto expiring on January 16, 2023 concerns rise for the Swiss multinational...

Maharashtra State Commission directs DCDRC to decide medical negligence case on merits within 3 months

CDSCO orders inspection of pharmacovigilance system of importers, manufacturers of human vaccines

Farhat Nasim5 Jan 2023 6:00 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has recently ordered inspections/audits of pharmacovigilance system of importers...

No tax deduction on freebies to doctors: Pharma company disallowed booking Rs 21 lakh as expense by ITAT

Farhat Nasim3 Jan 2023 3:32 PM IST

Chennai: Holding that freebies to medical practitioners are prohibited by law, the Chennai bench of the Income Tax Appellate Tribunal (ITAT) has...

Re-labelling for price revision not mandatory if drug makers ensure price compliance: NPPA

Farhat Nasim2 Jan 2023 3:03 PM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has clarified that recalling or re-labelling of...

Govt Invites Pharma Firms to Submit Data for Ceiling Price Review

DoP designates OSD for Export Promotion Council for Medical Devices

Farhat Nasim30 Dec 2022 6:00 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has designated an official from the Engineering Export Promotion Council (EEPC) India as the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok